Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017

Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences

Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder

Adams, T. G., Bloch, M. H., & Pittenger, C. | Journal of clinical psychopharmacology | 1 March 2017

Psychedelics and the science of self-experience

Nour, M. M., & Carhart-Harris, R. L. | The British Journal of Psychiatry | 1 March 2017

Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review

Hamid, H. A., Ramli, A. N., & Yusoff, M. M. | Frontiers in Pharmacology | 28 February 2017

Effects of Hallucinogens on Neuronal Activity

Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano-Rodríguez, E., Santana, N., & Artigas, F. | Current Topics in Behavioural Neuroscience | 26 February 2017

Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 23 February 2017

Safety pharmacology of acute MDMA administration in healthy subjects

Vizeli, P., & Liechti, M. E. | Journal of Psychopharmacology | 21 February 2017

Hallucinogenic Drugs: A New Study Answers Old Questions about LSD

Halberstadt, A. L. | Current Biology | 20 February 2017

22-azidosalvinorin A exhibits antidepressant-like effect in mice

Fajemiroye, J. O., Prabhakar, P. R., da Cunha, C. L., Costa, E. A., & Zjawiony, J. K. | European Journal of Pharmacology | 17 February 2017

Altered Insula Connectivity Under MDMA

Walpola, I. C., Nest, T., Roseman, L., Erritzoe, D., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 14 February 2017

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. | Clinical Pharmacokinetics | 14 February 2017

The association of psychedelic use and opioid use disorders among illicit users in the United States

Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. | Journal of Psychopharmacology | 14 February 2017

Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine

Dakic, V., Nascimento, J. M., Sartore, R. C., de Moraes Maciel, R., de Araujo, D. B., Ribeiro, S., ... & Rehen, S. K. | bioRxiv | 13 February 2017

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics

Cruz, A., Domingos, S., Gallardo, E., & Martinho, A. | Phytochemistry | 10 February 2017

Rapid antidepressant effect of ketamine correlates with astroglial plasticity in the hippocampus

Ardalan, M., Rafati, A. H., Nyengaard, J. R., & Wegener, G. | British Journal of Pharmacology | 8 February 2017

Sub-anesthetic doses of ketamine exert antidepressant-like effects and upregulate the expression of glutamate transporters in the hippocampus of rats

Zhu, X., Ye, G., Wang, Z., Luo, J., & Hao, X. | Neuroscience Letters | 3 February 2017

Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience

Juszczak, G. R. | Medical Hypotheses | 3 February 2017

Effect of a Hallucinogenic Serotonin 5-HT2A Receptor Agonist on Visually-Guided, Hippocampal-Dependent Spatial Cognition in C57BL/6J Mice

Zhang, G., Cinalli, D., & Stackman, R. W. | Hippocampus | 1 February 2017

Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task

Rychlik, M., Bollen, E., & Rygula, R. | Psychopharmacology | 1 February 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial

Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M., Pessoa, J., ... & Tofoli, L. | bioRxiv | 27 January 2017

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., ... & Vollenweider, F. X. | Current Biology | 26 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. | Medical Hypotheses | 23 January 2017